Clinical trials
Suspended Lung Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2012 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Guard Health Affairs | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Cancer Research UK | 1 |
| Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | 1 |
| Chongqing Precision Biotech Co., Ltd | 1 |
| City of Hope Medical Center | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Dwight Owen | 1 |
| Guangzhou Women and Children's Medical Center | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 22 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Neoplasms | 5 |
| Breast Neoplasms | 3 |
| Colorectal Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
| Carcinoma, Renal Cell | 2 |
| Prostatic Neoplasms | 2 |
| Small Cell Lung Carcinoma | 2 |
Trials
Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.